Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

IRWDIRWD
Showing 5 of 28 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in IRONWOOD PHARMACEUTICALS INC

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC previously held 0 shares of IRWD (IRONWOOD PHARMACEUTICALS INC), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$1.1M

Total Shares Change

-269,725

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$1.42
0
2025-Q2
Decreased
21,643
-92.5%
$15,5180.0%$0.73
0
2025-Q1
Unchanged
286,990
0.0%
$421,8750.0%$1.41
0
2024-Q4
Increased
286,990
+6.4%
$1.3M0.0%$4.38
27
2024-Q3
Decreased
269,725
-12.6%
$1.1M0.0%$4.02
0

Other major holders of IRWD: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used